You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Uveal Neoplasms

Showing 1 - 25 of 686
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Psychoeducation for Uveal Melanoma

Not yet recruiting
  • Uveal Melanoma
  • Education for Intervention
  • Best Practice
  • (no location specified)
Oct 4, 2023

Uveal Melanoma Trial in Vienna (any therapy suitable)

Recruiting
  • Uveal Melanoma
  • any therapy suitable
  • Vienna, Austria
    Medical University of Vienna
Feb 8, 2023

Phase of Uveal Melanoma: A Prospective Multi-method Study

Not yet recruiting
  • Uveal Melanoma
  • Questionnaires and interviews
  • (no location specified)
Oct 4, 2023

Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Nov 2, 2023

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Melanoma, Uveal Tumors Trial in Gothenburg (IHP)

Active, not recruiting
  • Melanoma
  • Uveal Neoplasms
  • IHP
  • Gothenburg, Sweden
    Sahlgrenska University Hospital
Oct 26, 2022

Morphological, Genetic and Tumour Microenvironment

Recruiting
  • Uveal Melanoma
  • cytogenetic analysis on tumour tissue
  • Digital Pathology
  • Rome, Italy
    Monica Maria Pagliara - Oncologia Oculare
May 26, 2023

Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

Recruiting
  • Metastatic Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Aug 14, 2023

Uveal Melanoma Trial in Nice, Paris (Supportive care visit with questionnaires, Oncological standard visit)

Recruiting
  • Uveal Melanoma
  • Supportive care visit with questionnaires
  • Oncological standard visit
  • Nice, France
  • +1 more
Jan 19, 2023

Uveal Tumors, Melanoma, Uveal Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Uveal Neoplasms
  • Melanoma, Uveal
  • Tumor Infiltrating Lymphocytes (TIL)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 21, 2022

Stage IV Uveal Melanoma Trial in Philadelphia (Sir-Spheres®)

Active, not recruiting
  • Stage IV Uveal Melanoma
  • Sir-Spheres®
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 20, 2022

Advanced Uveal Melanoma, Metastatic Uveal Melanoma, Unresectable Uveal Melanoma Trial (BRD4 Inhibitor PLX2853, Trametinib,

Not yet recruiting
  • Advanced Uveal Melanoma
  • +2 more
  • BRD4 Inhibitor PLX2853
  • +4 more
  • (no location specified)
Jan 9, 2023

Uveal Melanoma Trial in San Francisco (stereotactic body radiotherapy, Immunotherapy)

Recruiting
  • Uveal Melanoma
  • San Francisco, California
    California Pacific Medical Center Research Institute
Dec 2, 2022

Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

Recruiting
  • Uveal Melanoma
  • +3 more
  • Lifileucel (LN-144)
  • Harrison, New York
  • +1 more
Nov 8, 2022

Uveal Melanoma, Uveal Melanoma, Posterior, Medium/Large Size, Eye Cancer, Intraocular Melanoma Trial in Stockholm (Melatonin)

Not yet recruiting
  • Uveal Melanoma
  • +2 more
  • Stockholm, Sweden
    St. Erik Eye Hospital
Aug 14, 2022

Uveal Melanoma Trial in Minneapolis (PAC-1, Entrectinib)

Active, not recruiting
  • Uveal Melanoma
  • Minneapolis, Minnesota
    HealthPartners Institute Regions Cancer Care Center
Nov 15, 2022

Metastatic Uveal Melanoma Trial in Miami (Nivolumab, Relatlimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center
Aug 23, 2022

Metastatic Uveal Melanoma Trial in Tampa (Binimetinib, Belinostat)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Jun 21, 2022

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in Philadelphia

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +2 more
  • Ipilimumab
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 15, 2022

Metastatic Uveal Melanoma Trial in Philadelphia (Defactinib Hydrochloride, Raf/MEK Inhibitor VS-6766)

Recruiting
  • Metastatic Uveal Melanoma
  • Defactinib Hydrochloride
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023

Metastatic Uveal Melanoma Trial in Paris (Pembrolizumab 25 MG/1 ML Intravenous Solution)

Recruiting
  • Metastatic Uveal Melanoma
  • Pembrolizumab 25 MG/1 ML Intravenous Solution
  • Paris, France
    Institut Curie
Aug 3, 2022

Uveal Melanoma Trial in Worldwide (LXS196, LXS196 and HDM201)

Terminated
  • Uveal Melanoma
  • New York, New York
  • +5 more
Sep 27, 2022

Uveal Melanoma Trial in New York, Houston (Selumetinib)

Active, not recruiting
  • Uveal Melanoma
  • New York, New York
  • +2 more
Jun 28, 2022

Uveal Melanoma, Metastatic Trial in Leiden (Ipilimumab and nivolumab, Melphalan chemosaturation via percutaneous hepatic

Recruiting
  • Uveal Melanoma, Metastatic
  • Ipilimumab and nivolumab
  • Melphalan chemosaturation via percutaneous hepatic perfusion
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Apr 8, 2022

Uveal Melanoma Trial in Spain (Tislelizumab, Sitravatinib Malate)

Not yet recruiting
  • Uveal Melanoma
  • Málaga, Andalucia, Spain
  • +5 more
Sep 13, 2022